Inactive Instrument

Analyst Reco. DermTech, Inc. Nasdaq

Equities

VGG2379F1247

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

Lake Street Downgrades DermTech to Hold From Buy, Price Target is $0.63	04-19	MT
BTIG Downgrades DermTech to Neutral From Buy	04-19	MT
BTIG Adjusts DermTech's Price Target to $2 From $4, Maintains Buy Rating	03-07	MT
Stephens Trims Price Target on DermTech to $1.50 From $2.50, Keeps Equalweight Rating	03-05	MT
BTIG Adjusts Price Target on DermTech to $5 From $6, Maintains Buy Rating	23-08-07	MT
Stephens Adjusts Price Target on DermTech to $5 From $16, Maintains Overweight Rating	22-11-09	MT
BTIG Adjusts Price Target on DermTech to $6 From $15, Maintains Buy Rating	22-11-08	MT
William Blair Downgrades DermTech to Market Perform From Outperform	22-11-04	MT
Oppenheimer Adjusts DermTech Price Target to $13 From $23, Maintains Outperform Rating	22-11-04	MT
Oppenheimer Adjusts DermTech's Price Target to $23 From $48, Maintains Outperform Rating	22-08-17	MT
BTIG Adjusts DermTech's Price Target to $15 From $19, Reiterates Buy Rating	22-08-15	MT
Craig-Hallum Adjusts DermTech's Price Target to $18 from $37, Maintains Buy Rating	22-08-09	MT
Oppenheimer Adjusts DermTech Price Target to $48 From $58, Maintains Outperform Rating	22-03-02	MT
Stephens Initiates DermTech With Overweight Rating, $26 Price Target	22-01-07	MT
Stephens Starts DermTech at Overweight	22-01-07	MT
BTIG Adjusts DermTech's Price Target to $48 From $53, Reiterates Buy Rating	21-11-22	MT
DERMTECH : BTIG Initiates DermTech at Buy With $53 Price Target	21-05-03	MT
DERMTECH : Oppenheimer Adjusts DermTech PT to $58 From $53 Following In Line Q4 Results, Maintains Outperform	21-03-05	MT
DERMTECH : Craig Hallum Adjusts DermTech PT to $70 From $49, Maintains Buy Rating	21-03-05	MT
DERMTECH : Oppenheimer Starts DermTech at Outperform With $53 Price Target	21-01-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. DermTech, Inc. Nasdaq

Equities

VGG2379F1247

Analyst Reco.

Filters